Study details
Enrolling now
Anti Inflammatory Lipid Mediators in Asthma
University of Colorado, Denver
NCT IDNCT03762395ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
60
Study length
about 7 years
Ages
18–65
Locations
1 site in CO
About this study
This trial is testing a treatment called CXA-10 to see if it helps people with asthma and obesity. The goal is to determine if CXA-10 reduces inflammation in the lungs, which can worsen asthma symptoms.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take CXA-10
- 2.Take Matching Placebo
PhasePhase 2
Primary goalChanges in pre-bronchodilator FEV1 per spirometry
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low12%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Changes in pre-bronchodilator FEV1 per spirometry
Body systems
Endocrinology, Respiratory